Mike Owen, Phd
Bussiness And Management
Blink Biomedical
United States of America
Biography
He serves as a director of Zealand Pharma, Ossianix Inc and BlinK Biomedical SAS, sits on the Scientific Advisory Boards of Kymab Ltd, the CRT Pioneer Fund LP and HS Lifesciences, and is a member of the Sanofi Aventis Oncology Board. Mike was formally Senior Vice President for Biopharmaceuticals Research at GlaxoSmithKline where he was responsible for the discovery and development of antibody drugs through to successful clinical proof of concept. He was also a Founder and Chief Scientific Officer of Kymab Ltd, an antibody based biotech company, and for many years held a research position at the Imperial Cancer Research Fund. He was elected a Fellow of the UK Academy of Medical Sciences and a member of the European Molecular Biology Organisation.
Research Interest
business
